Single-fraction stereotactic body radiotherapy for nodal oligorecurrent prostate cancer

被引:0
|
作者
Loi, M. [1 ]
Simontacchi, G. [2 ]
Detti, B. [2 ]
Di Cataldo, V. [3 ]
Bonomo, P. [2 ]
Masi, L. [3 ]
Doro, R. [3 ]
Bonucci, I. [3 ]
Cipressi, S. [3 ]
Desideri, I. [2 ]
Greto, D. [2 ]
Becherini, C. [2 ]
Delli Paoli, C. [2 ]
Grassi, R. [2 ]
Lo Russo, M. [2 ]
Meattini, I. [2 ]
Scoccianti, S. [2 ]
Mangoni, M. [2 ]
Livi, L. [2 ]
机构
[1] Azienda Osped Univ Careggi, Radiotherapy Unit, Florence, Italy
[2] Univ Florence, Radiotherapy Dept, Florence, Italy
[3] IFCA, Radiotherapy Dept, Florence, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP-1352
引用
收藏
页码:S724 / S725
页数:2
相关论文
共 50 条
  • [1] Single-Fraction Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Relapse in Prostate Cancer
    Loi, Mauro
    Di Cataldo, Vanessa
    Francolini, Giulio
    Bonomo, Pierluigi
    Masi, Laura
    Simontacchi, Gabriele
    Detti, Beatrice
    Greto, Daniela
    Desideri, Isacco
    Livi, Lorenzo
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (11) : 703 - 705
  • [2] The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus?
    Wee Loon Ong
    Andrew Loblaw
    World Journal of Urology, 2023, 41 : 3485 - 3491
  • [3] Duodenal Toxicity in Single-fraction Stereotactic Body Radiotherapy
    Murphy, J. D.
    Dieterich, S.
    Chang, D. T.
    Koong, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S29 - S30
  • [4] The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus?
    Ong, Wee Loon
    Loblaw, Andrew
    WORLD JOURNAL OF UROLOGY, 2023, 41 (12) : 3485 - 3491
  • [5] Radiotherapy in nodal oligorecurrent prostate cancer
    Pinkawa, Michael
    Aebersold, Daniel M.
    Boehmer, Dirk
    Flentje, Michael
    Ghadjar, Pirus
    Schmidt-Hegemann, Nina-Sophie
    Hoecht, Stefan
    Hoelscher, Tobias
    Mueller, Arndt-Christian
    Niehoff, Peter
    Sedlmayer, Felix
    Wolf, Frank
    Zamboglou, Constantinos
    Zips, Daniel
    Wiegel, Thomas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (07) : 575 - 580
  • [6] Radiotherapy in nodal oligorecurrent prostate cancer
    Michael Pinkawa
    Daniel M. Aebersold
    Dirk Böhmer
    Michael Flentje
    Pirus Ghadjar
    Nina-Sophie Schmidt-Hegemann
    Stefan Höcht
    Tobias Hölscher
    Arndt-Christian Müller
    Peter Niehoff
    Felix Sedlmayer
    Frank Wolf
    Constantinos Zamboglou
    Daniel Zips
    Thomas Wiegel
    Strahlentherapie und Onkologie, 2021, 197 : 575 - 580
  • [7] Salvage stereotactic body radiotherapy for lymph node oligorecurrent prostate cancer
    Fanetti, G.
    Fodor, C.
    Ciardo, D.
    Santoro, L.
    Francia, C. M.
    Muto, M.
    Surgo, A.
    Zerini, D.
    Marvaso, G.
    Timon, G.
    Romanelli, P.
    Rondi, E.
    Comi, S.
    Cattani, F.
    Matei, D. V.
    Ferro, M.
    Musi, G.
    Nole, F.
    De Cobelli, O.
    Ost, P.
    Orecchia, R.
    Jereczek-Fossa, B. A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S719 - S720
  • [8] Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking
    Jaccard, Maud
    Ehrbar, Stefanie
    Miralbell, Raymond
    Hagen, Tobias
    Koutsouvelis, Nikolaos
    Poulsen, Per
    Rouzaud, Michel
    Tanadini-Lang, Stephanie
    Tsoutsou, Pelagia
    Guckenberger, Matthias
    Zilli, Thomas
    RADIOTHERAPY AND ONCOLOGY, 2021, 156 : 145 - 152
  • [9] Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer
    Schellenberg, Devin
    Goodman, Karyn A.
    Lee, Florence
    Chang, Stephanie
    Kuo, Timothy
    Ford, James M.
    Fisher, George A.
    Quon, Andrew
    Desser, Terry S.
    Norton, Jeffrey
    Greco, Ralph
    Yang, George P.
    Koong, Albert C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 678 - 686
  • [10] Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung- The Knockout Punch
    Tjong, M. C.
    Louie, A., V
    Singh, A. K.
    Videtic, G.
    Stephans, K.
    Plumridge, N.
    Harden, S.
    Slotman, B. J.
    Alongi, F.
    Guckenberger, M.
    Siva, S.
    CLINICAL ONCOLOGY, 2022, 34 (05) : E183 - E194